EichorEICHOR
Location: Swansea Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Swansea

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 5989 · Galderma R&D · NCT06988605
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Morriston Hospital · Amgen · NCT07037433
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Singleton Hospital · Loxo Oncology, Inc. · NCT05254743
International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
Phase 3 · Swansea Bay University Health Board · Institute of Cancer Research, United Kingdom · NCT02305654
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Phase 2/Phase 3 · Swansea Bay University Health Board · Exelixis · NCT06943755
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase 3 · Swansea University · Eli Lilly and Company · NCT07223593
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Southwest Illinois Health Services LLP · Alliance for Clinical Trials in Oncology · NCT04242095
Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)
Phase N/A · Singleton Hospital, Swansea · University Hospital Southampton NHS Foundation Trust · NCT06440174
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263
Global Trial in APG2575 for Patients With CLL/SLL
Phase 3 · Ascentage Investigative Site · Ascentage Pharma Group Inc. · NCT06104566
Isometric Handgrip Training Frequency and Blood Pressure in People With Hypertension
NA · Swansea University · Swansea University · NCT06335433
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109
Adult SMA Research and Clinical Hub
Phase N/A · South West Wales Neuromuscular Service in Swansea · Newcastle-upon-Tyne Hospitals NHS Trust · NCT06978985
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NA · Morriston Hospital · University of Leicester · NCT04204915
AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
NA · Singleton Hospital - ABM University Health Board · Jules Bordet Institute · NCT02102165
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60
Phase 2 · Southwest Illinois Health Services LLP · SWOG Cancer Research Network · NCT04511013
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Southwest Illinois Health Services LLP · ECOG-ACRIN Cancer Research Group · NCT04239573
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Southwest Illinois Health Services LLP · SWOG Cancer Research Network · NCT04205968
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · Southwest Illinois Health Services LLP · ECOG-ACRIN Cancer Research Group · NCT02734537
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Phase 3 · Morriston Hospital · Vedanta Biosciences, Inc. · NCT06237452
Cryoballoon/Radiofrequency/Pulsed Field Ablation of Atrial Fibrillation Versus Medical Treatment for Heart
NA · Swansea Bay University Health Board · University College, London · NCT06505798
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · Southwest Illinois Health Services LLP · SWOG Cancer Research Network · NCT03418961
Effect of Brief-tele Support on Attendance at Physiotherapy Sessions
NA · Singleton Hospital · Swansea University · NCT02563600
Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser f
Phase 3 · Singleton Hospital · Belfast Health and Social Care Trust · NCT06985706
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Southwest Illinois Health Services LLP · SWOG Cancer Research Network · NCT03723928
Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Sur
NA · Tonna Hospital · Imperial College London · NCT04103372
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · Southwest Illinois Health Services LLP · National Cancer Institute (NCI) · NCT03866382
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Southwest Illinois Health Services LLP · National Cancer Institute (NCI) · NCT04267848
"Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)
NA · Morriston Hospital · Imperial College London · NCT05815745
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy o
Phase 3 · Research Site · AstraZeneca · NCT06380751
Look up another city
Look up another condition